Browsing Category

24353 posts
Xinhua Silk Road: Chinese tea embraces new opportunities shared by the world

Xinhua Silk Road: Chinese tea embraces new opportunities shared by the world

BEIJING, Dec. 22, 2025 /PRNewswire/ — China’s tea industry is shifting from a…
Tencent Cloud Launches EdgeOne Pages Official Version, Strengthening Its End-to-End AI Strategy

Tencent Cloud Launches EdgeOne Pages Official Version, Strengthening Its End-to-End AI Strategy

Official release follows successful beta with 150,000 users, empowering developers to build…
Social Enterprise Research Academy conducted "2025 ESG Leader Summit -Tech for Good"& Signed MOU with CIAPST to facilitate Cooperation between Mainland China and Hong Kong Uniting Forces from All Sectors for Collaboration

Social Enterprise Research Academy conducted "2025 ESG Leader Summit -Tech for Good"& Signed MOU with CIAPST to facilitate Cooperation between Mainland China and Hong Kong Uniting Forces from All Sectors for Collaboration

HONG KONG, Dec. 22, 2025 /PRNewswire/ — The "2024/25 ESG Leader Summit…

Mirae Asset's Global ETF Platform Surpasses $200 Billion In AUM, Marking a New Growth Milestone

Firm’s ETF assets have doubled in recent years, reflecting its innovative ETF…

Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability

SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ — In an increasingly digital era,…

Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype

The secondary analysis of the PACE trial highlights the value of counting…
Beko Secures €100 Million Sustainability-Linked Loan from IFC to Drive Global Innovation and Net-Zero Transformation

Beko Secures €100 Million Sustainability-Linked Loan from IFC to Drive Global Innovation and Net-Zero Transformation

Beko has secured its first sustainability-linked loan to expand renewable energy capacity,…

Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy

Guardant360® CDx is the first companion diagnostic to be approved in Japan…